Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy

Publication | Closed Access

DOI

Citations

References

2016

Year

Giuseppe Tarantini, Luca Nai Fovino, Paola Tellaroli, Alaide Chieffo, Alberto Barioli, Alberto Menozzi, Arian Frasheri, Roberto Garbo, Mónica Masotti-Centol, Neus Salvatella,

International Journal of Cardiology

ThrombosisDiabetes ManagementDual Antiplatelet TherapyOptimal DurationCardiovascular DiseaseEndovascular TechniqueDiabetesSurgeryPlatelet AntagonistMedicineAtherosclerosisCoronary Artery Disease